1
Country: USA | Funding: $200M
AirNexis has exclusive rights to develop AN01- drug for chronic obstructive pulmonary disease (COPD) outside of China from Haisco Pharmaceutical Group. AN01 is a dual PDE3/4 inhibitor that exerts synergistic effects through a dual mechanism of action (MOA) that promotes bronchodilation and reduces the release of inflammatory factors.
AirNexis has exclusive rights to develop AN01- drug for chronic obstructive pulmonary disease (COPD) outside of China from Haisco Pharmaceutical Group. AN01 is a dual PDE3/4 inhibitor that exerts synergistic effects through a dual mechanism of action (MOA) that promotes bronchodilation and reduces the release of inflammatory factors.
2
Country: Germany | Funding: $125M
kaia is a digital therapeutics company focused on AI-powered management of chronic pain
kaia is a digital therapeutics company focused on AI-powered management of chronic pain
3
Country: UK | Funding: £18M
A drug discovery and development company focused on advancing novel approaches for severe respiratory conditions
A drug discovery and development company focused on advancing novel approaches for severe respiratory conditions
4
Country: UK | Funding: £68.8M
Enterprise Therapeutics is a drug discovery company dedicated to the research and development of novel therapies for the treatment of respiratory diseases. In diseases such as cystic fibrosis, asthma and COPD the lungs become congested with mucus leading to difficulty in breathing. New disease modifying therapies that target the underlying mechanisms of mucus congestion will reduce the frequency of lung infections and improve patient quality of life.
Enterprise Therapeutics is a drug discovery company dedicated to the research and development of novel therapies for the treatment of respiratory diseases. In diseases such as cystic fibrosis, asthma and COPD the lungs become congested with mucus leading to difficulty in breathing. New disease modifying therapies that target the underlying mechanisms of mucus congestion will reduce the frequency of lung infections and improve patient quality of life.
5
Country: USA | Funding: $33.2M
VIDA is a leader in quantitative lung analysis for COPD, emphysema and asthma, establishing objective, reproducible and quantitative
VIDA is a leader in quantitative lung analysis for COPD, emphysema and asthma, establishing objective, reproducible and quantitative
6
Country: Sweden | Funding: $28.2M
NuvoAir combines hardware, software and data to improve lives of people suffering from respiratory conditions
NuvoAir combines hardware, software and data to improve lives of people suffering from respiratory conditions
7
Country: Israel | Funding: $28M
Inspira Technologies is an innovative medical technology company. Inspira develops a cost-effective minimally invasive Extracorporeal Respiratory Support technology (ECRS), which the company believes has the potential to utilize oxygen to rebalance patients' saturation levels while they are awake. Inspira’s technology has the potential to prevent the need for mechanical ventilation.
Inspira Technologies is an innovative medical technology company. Inspira develops a cost-effective minimally invasive Extracorporeal Respiratory Support technology (ECRS), which the company believes has the potential to utilize oxygen to rebalance patients' saturation levels while they are awake. Inspira’s technology has the potential to prevent the need for mechanical ventilation.
8
Country: USA | Funding: $23.3M
Pneuma Respiratory is focused on creating therapeutic treatments for diseases of the lungs using a digital first platform for inhaled drug delivery. Our focus is to improve the potential effectiveness of currently available and novel drugs, with the initial targets being approved therapeutics for asthma and COPD.
Pneuma Respiratory is focused on creating therapeutic treatments for diseases of the lungs using a digital first platform for inhaled drug delivery. Our focus is to improve the potential effectiveness of currently available and novel drugs, with the initial targets being approved therapeutics for asthma and COPD.
9
Country: USA | Funding: $22M
Telesair creates Respiratory Humidifier, designed for use in the ICU, and support the development of a new product that aims to help patients leave the hospital more quickly and stay at home safely.
Telesair creates Respiratory Humidifier, designed for use in the ICU, and support the development of a new product that aims to help patients leave the hospital more quickly and stay at home safely.
10
Country: USA | Funding: $16.8M
Cohero developed a connected spirometer to assess lung function and medication adherence in asthma and COPD patients. It was designed to be a clinical grade medical device to function as a barometer for lung function. It also produced a patient-facing app that helps users track their data.
Cohero developed a connected spirometer to assess lung function and medication adherence in asthma and COPD patients. It was designed to be a clinical grade medical device to function as a barometer for lung function. It also produced a patient-facing app that helps users track their data.
11
Country: USA | Funding: $15.7M
Sentrian developed a biosensor supported by cloud technology and machine to detect deteriorating health of patients earlier.
Sentrian developed a biosensor supported by cloud technology and machine to detect deteriorating health of patients earlier.
12
Country: New Zealand | Funding: $15.4M
Adherium provides digital health solutions for respiratory conditions including asthma and COPD.
Adherium provides digital health solutions for respiratory conditions including asthma and COPD.
13
Country: Cyprus | Funding: €10M
Liita Care is a MedTech company focused on Respiratory Health. We are committed to improve quality of life for patients and healthy consumers by developing and manufacturing new and better therapies and medical devices for respiratory health management.
Liita Care is a MedTech company focused on Respiratory Health. We are committed to improve quality of life for patients and healthy consumers by developing and manufacturing new and better therapies and medical devices for respiratory health management.
14
Country: Israel | Funding: €10M
NanoVation provides monitoring solutions for patients with chronic respiratory diseases.
NanoVation provides monitoring solutions for patients with chronic respiratory diseases.
15
Country: USA | Funding: $5M
LifeMap Solutions develops a m-Health platform that integrates disparate sources of information to generate an accurate picture of an individual's health. One of the primary apps is COPD Navigator app.
LifeMap Solutions develops a m-Health platform that integrates disparate sources of information to generate an accurate picture of an individual's health. One of the primary apps is COPD Navigator app.
16
Country: Germany | Funding: €4.7M
VisionHealth supports patients with chronic lung diseases who are dependent on their inhaler.
VisionHealth supports patients with chronic lung diseases who are dependent on their inhaler.
17
Country: UK | Funding: £2.5m
Pure is a private medical facility, the first of its kind in the UK, providing innovative science-backed treatments & therapies.
Pure is a private medical facility, the first of its kind in the UK, providing innovative science-backed treatments & therapies.
18
Country: UK | Funding: $3M
Arete Medical Technologies is a startup creating medical devices and software for precision approaches to chronic diseases, starting with asthma and COPD.
Arete Medical Technologies is a startup creating medical devices and software for precision approaches to chronic diseases, starting with asthma and COPD.
19
Country: Belgium | Funding: €1M
ArtiQ developed AI-based software that automatically processes pulmonary function test (PFT) data and generates a clinical report. It provides cloud-based coupling and synchronization with either electronic patient records or directly with PFT machines. The AI report is stored in the patient file immediately.
ArtiQ developed AI-based software that automatically processes pulmonary function test (PFT) data and generates a clinical report. It provides cloud-based coupling and synchronization with either electronic patient records or directly with PFT machines. The AI report is stored in the patient file immediately.
20
Country: USA | Funding: $100K
Wellinks is a hardware enabled digital health company focused on reinventing respiratory care around the people who need it.
Wellinks is a hardware enabled digital health company focused on reinventing respiratory care around the people who need it.
21
Country: Israel
NE Field Diagnostics develops an innovative technology for pulmonary function testing and monitoring
NE Field Diagnostics develops an innovative technology for pulmonary function testing and monitoring
